ABRYSVO
ABRYSVO
Approved
DIN Number
02544040
Drug Class
Human
Market Date
May 22, 2024
Company
HC
Pfizer Canada Ulc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02544040
AIG Number0265562001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J07BX05 RESPIRATORY SYNCYTIAL VIRUS VACCINE
Product Specifications
Dosage FormPowder For Solution
,
Kit
Route of AdministrationIntramuscular
AHFS Classification80:12.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
RSV SUBGROUP A STABILIZED PREFUSION F PROTEINActive
Strength: 60 MCG / 0.5 ML
Monograph: RSV SUBGROUP A STABILIZED PREFUSION F PROTEIN
RSV SUBGROUP B STABILIZED PREFUSION F PROTEINActive
Strength: 60 MCG / 0.5 ML
Monograph: RSV SUBGROUP B STABILIZED PREFUSION F PROTEIN